Global Schools Group Opens One World International Digital Campus, Pioneering Digital and Sustainable Education in Singapore
SINGAPORE, Dec. 10, 2024 /PRNewswire/ -- One World International School (OWIS) officially opened a first-of-its-kind Digital Campus on 9 December, with Ms Yeo Wan Ling, Member of Parliament of Pasir Ris-Punggol GRC, in attendance. This milestone...
2024 Understanding China Conference Concludes Successfully: A New Path for Global Understanding of Chinese Modernization
GUANGZHOU, China, Dec. 10, 2024 /PRNewswire/ -- The 2024 Understanding China International Conference concluded after three days of insightful discussions, bringing together political leaders, scholars, business executives, and representatives from...
Live from ASH 2024 | Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax in Combinations Demonstrates Potential Clinical Benefit in Patients with Prior Exposure to Venetoclax
ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for...
The new battleground for commercial card providers: Rewards and flexibility, Ascenda report reveals
Fintech disruption and evolving rewards reshape business spending landscape NEW YORK, Dec. 10, 2024 /PRNewswire/ -- Ascenda, the global leader in loyalty as a service, today released its 2024 State of Loyalty: Commercial Cards report. The report...
Live from ASH 2024 | First Dataset of Olverembatinib as Second-Line Therapy in Patients with Non-T315I-Mutant CP-CML Presented in Oral Report
ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for...
Live from ASH 2024 | 1.5-Year Follow-Up Data from a Global Study of Olverembatinib Reaffirms Potential in Overcoming Resistance/Intolerance to Ponatinib or Asciminib
ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for...
Bring Christmas Cheer to Your Home with Yaber Projectors: Holiday Sale Now Live on Amazon
NEW YORK, Dec. 10, 2024 /PRNewswire/ -- This holiday season, Yaber invites you to make your celebrations brighter with its cutting-edge projectors, now available at irresistible discounts on Amazon. Whether you're planning cozy movie nights, festive...
Waters Highlights Continued Progress Towards Sustainability Commitments
News Summary: Exceeded its goal of reducing Scope 1 and 2 greenhouse gas emissions by 36% from a 2016 baseline, two years ahead of schedule. Invested in STEM education through the Waters Student Academy and Waters internship program, reaching...